« Previous
Next »
The American Journal of Surgery
Volume 186, Issue 4
, Pages 368-370
, October 2003
Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ
References
- . Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–772
-
Schwartz GF, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 2000;88:946–54
-
Pendas S, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15–20
-
Klauber-DeMore N, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-Situ with microinvasion? Ann Surg Oncol 2000;7:636–42
-
Cox CE, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513–21
-
McMasters KM, et al. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 2002;95:15–20
-
Intra M, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309–13
PII: S0002-9610(03)00276-9
doi: 10.1016/S0002-9610(03)00276-9
© 2003 Excerpta Medica Inc. All rights reserved.
« Previous
Next »
The American Journal of Surgery
Volume 186, Issue 4
, Pages 368-370
, October 2003
